Open Content

Subscribe today for access to
Articles and Reports

By Glenn S. Demby | Sep 21, 2023 | 2 min read

The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.

By Rachel Muenz | Sep 21, 2023 | 1 min read

Billing and coding consultant Diana Voorhees shares her tips to ensure compliance when billing laboratory services.

By Rachel Muenz | Sep 6, 2023 | 2 min read

The FDA recently submitted its own proposed rule relating to lab-developed test regulation for review.

By Rachel Muenz | Dec 7, 2022 | 2 min read

Co-owners sentenced to three years each for paying millions in kickbacks for referrals to their Brooklyn-based facilities.

By Glenn S. Demby | Dec 7, 2022 | 2 min read

While civil actions, criminal actions, and exclusions are up, the increased activity isn’t yet reflected in total recoveries.

By Rachel Muenz | Dec 6, 2022 | 3 min read

A recent study led by a team at the University of Gothenburg shows that multiple biomarkers could ID the disease even in people with no symptoms.

By Glenn S. Demby | Dec 5, 2022 | 2 min read

Learn why this is the perfect time of the year to mobilize your board members.

By Rachel Muenz | Nov 30, 2022 | 2 min read

Readers can now gain full access to our four briefings for up to seven days for free.

By Glenn S. Demby | Nov 30, 2022 | 2 min read

The company’s third attempt at shaking up the healthcare industry, Amazon Clinic, might just prove the charm.

By Rachel Muenz | Nov 30, 2022 | 2 min read

Enforcement actions over our most recent coverage period were related to other areas of the healthcare industry.

By Glenn S. Demby | Nov 28, 2022 | 2 min read

M&A deals in the diagnostics industry have been lower in number, but higher in impact in recent months.

By Rachel Muenz | Nov 23, 2022 | 4 min read

On Nov. 15, a psychiatrist and clinical lab owner pled guilty to his role in a complicated $3.8 million fraud scheme.

By Glenn S. Demby | Nov 23, 2022 | 4 min read

US takes first steps to rein in abusive and privacy-invasive use of AI by corporations.